(Bloomberg) — Mankind Pharma Ltd. is set to start trading in Mumbai on Tuesday after raising 43.3 billion rupees ($529 million) in one of India’s largest initial public offerings of the year. Shareholders of the drug and contraceptive maker sold 40 million shares at 1,080 rupees apiece, the top of…Read More
Condom Maker Set for Trading Debut in Mumbai Testing Appetite for India IPOs
